Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

External Correlates of the MMPI-2-Restructured Form across a National Sample of Veterans.

Ingram PB, Tarescavage AM, Ben-Porath YS, Oehlert ME, Bergquist BK.

J Pers Assess. 2020 Mar 6:1-8. doi: 10.1080/00223891.2020.1732995. [Epub ahead of print]

PMID:
32141772
2.

10D1F, an Anti-HER3 Antibody that Uniquely Blocks the Receptor Heterodimerization Interface, Potently Inhibits Tumor Growth Across a Broad Panel of Tumor Models.

Thakkar D, Sancenon V, Taguiam MM, Guan S, Wu Z, Ng E, Paszkiewicz KH, Ingram PJ, Boyd-Kirkup JD.

Mol Cancer Ther. 2020 Feb;19(2):490-501. doi: 10.1158/1535-7163.MCT-19-0515. Epub 2020 Jan 7.

PMID:
31911530
3.

Evaluating the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) over-reporting scales in a military neuropsychology clinic.

Ingram PB, Golden BL, Armistead-Jehle PJ.

J Clin Exp Neuropsychol. 2020 Apr;42(3):263-273. doi: 10.1080/13803395.2019.1708271. Epub 2020 Jan 3.

PMID:
31900041
4.

The effects of a working memory load on drinking-related decisions: The role of incentives, disincentives, and lifetime alcohol problems.

Ingram PF, Finn PR.

Drug Alcohol Depend. 2019 Nov 1;204:107567. doi: 10.1016/j.drugalcdep.2019.107567. Epub 2019 Sep 20.

PMID:
31563095
5.

Disinhibited personality, incentives, disincentives, and drinking-related decisions.

Finn PR, Fisher L, Mayer H, Ingram P, Howe L, Atkinson E.

Alcohol. 2020 Feb;82:53-61. doi: 10.1016/j.alcohol.2019.08.004. Epub 2019 Aug 28.

PMID:
31472266
6.

Comparing MMPI-2-Restructured Form Scores by Service Era for Veterans Assessed Within the Veteran Affairs Healthcare System.

Ingram PB, Tarescavage AM, Ben-Porath YS, Oehlert ME.

J Clin Psychol Med Settings. 2019 Aug 30. doi: 10.1007/s10880-019-09650-2. [Epub ahead of print]

PMID:
31471846
7.

Reconfigurable open microfluidics for studying the spatiotemporal dynamics of paracrine signalling.

Yu J, Berthier E, Craig A, de Groot TE, Sparks S, Ingram PN, Jarrard DF, Huang W, Beebe DJ, Theberge AB.

Nat Biomed Eng. 2019 Oct;3(10):830-841. doi: 10.1038/s41551-019-0421-4. Epub 2019 Aug 19.

PMID:
31427781
8.

Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).

Salmanton-García J, Seidel D, Koehler P, Mellinghoff SC, Herbrecht R, Klimko N, Ráčil Z, Falces-Romero I, Ingram P, Benítez-Peñuela MÁ, Rodríguez JY, Desoubeaux G, Barać A, García-Vidal C, Hoenigl M, Mehta SR, Cheng MP, Klyasova G, Heinz WJ, Iqbal N, Krause R, Ostermann H, Penack O, Schalk E, Sheppard DC, Willinger B, Wisplinghoff H, Vehreschild JJ, Cornely OA, Vehreschild MJGT; FungiScope® ECMM/ISHAM Working Group .

J Antimicrob Chemother. 2019 Nov 1;74(11):3315-3327. doi: 10.1093/jac/dkz344.

PMID:
31393591
9.

Antimicrobial stewardship opportunities among inpatients with diabetic foot infections: microbiology results from a tertiary hospital multidisciplinary unit.

Hand R, Manning L, Ritter JC, Norman P, Lamb L, Makepeace A, Sankhesara D, Hamilton E, Ingram P.

Intern Med J. 2019 Apr;49(4):533-536. doi: 10.1111/imj.14251.

PMID:
30957374
10.

Non-adherence to antimicrobial stewardship prospective audit and feedback advice: Risk factors and clinical consequences.

Horton CD, Rawlins MDM, Manning L, Ingram PR.

J Infect Chemother. 2019 Jun;25(6):485-488. doi: 10.1016/j.jiac.2019.02.011. Epub 2019 Mar 20.

PMID:
30904463
11.

Patterns of MMPI-2-Restructured Form (MMPI-2-RF) validity scale scores observed across Veteran Affairs settings.

Ingram PB, Tarescavage AM, Ben-Porath YS, Oehlert ME.

Psychol Serv. 2019 Feb 28. doi: 10.1037/ser0000339. [Epub ahead of print]

PMID:
30816738
12.

Pharmacokinetics of Ceftolozane-Tazobactam during Prolonged Intermittent Renal Replacement Therapy.

Rawlins M, Cheng V, Raby E, Dyer J, Regli A, Ingram P, McWhinney BC, Ungerer JPJ, Roberts JA.

Chemotherapy. 2018;63(4):203-206. doi: 10.1159/000493196. Epub 2018 Oct 10.

PMID:
30304718
13.

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.

Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN).

JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. Erratum in: JAMA. 2019 Jun 18;321(23):2370.

14.

Interaction with an endothelial lumen increases neutrophil lifetime and motility in response to P aeruginosa.

Hind LE, Ingram PN, Beebe DJ, Huttenlocher A.

Blood. 2018 Oct 25;132(17):1818-1828. doi: 10.1182/blood-2018-05-848465. Epub 2018 Aug 24.

15.

Managing diabetic foot infections: a survey of Australasian infectious diseases clinicians.

Commons RJ, Raby E, Athan E, Bhally H, Chen S, Guy S, Ingram PR, Lai K, Lemoh C, Lim LL, Manning L, Miyakis S, O'Reilly M, Roberts A, Sehu M, Torda A, Vicaretti M, Lazzarini PA.

J Foot Ankle Res. 2018 Apr 10;11:13. doi: 10.1186/s13047-018-0256-3. eCollection 2018.

16.

An Accessible Organotypic Microvessel Model Using iPSC-Derived Endothelium.

Ingram PN, Hind LE, Jiminez-Torres JA, Huttenlocher A, Beebe DJ.

Adv Healthc Mater. 2018 Jan;7(2). doi: 10.1002/adhm.201700497. Epub 2017 Aug 7.

17.

Sampling from single-cell observations to predict tumor cell growth in-vitro and in-vivo.

Pearson AT, Ingram P, Bai S, O'Hayer P, Chung J, Yoon E, Jackson T, Buckanovich RJ.

Oncotarget. 2017 Nov 25;8(67):111176-111189. doi: 10.18632/oncotarget.22693. eCollection 2017 Dec 19.

18.

Exploring paraprofessional and classroom factors affecting teacher supervision.

Irvin DW, Ingram P, Huffman J, Mason R, Wills H.

Res Dev Disabil. 2018 Feb;73:106-114. doi: 10.1016/j.ridd.2017.12.013. Epub 2017 Dec 26.

PMID:
29287228
19.

Successful outpatient parenteral antibiotic therapy delivery via telemedicine.

Tan SJ, Ingram PR, Rothnie AJ, Whitmore TJ, Robinson JO, Hatch JB, Italiano CM, Heath CH.

J Antimicrob Chemother. 2017 Oct 1;72(10):2898-2901. doi: 10.1093/jac/dkx203.

PMID:
29091189
20.

Tissue Acoustoelectric Effect Modeling From Solid Mechanics Theory.

Song X, Qin Y, Xu Y, Ingram P, Witte RS, Dong F.

IEEE Trans Ultrason Ferroelectr Freq Control. 2017 Oct;64(10):1583-1590. doi: 10.1109/TUFFC.2017.2724066. Epub 2017 Jul 7.

PMID:
28692972
21.

Optimizing adherence to advice from antimicrobial stewardship audit and feedback rounds.

Rawlins MDM, Sanfilippo FM, Ingram PR, McLellan DGJ, Crawford C, D'Orsogna L, Dyer J.

J Chemother. 2018 Feb;30(1):59-62. doi: 10.1080/1120009X.2017.1336318. Epub 2017 Jun 5.

PMID:
28580878
22.

Voriconazole-induced hyponatraemia associated with homozygous CYP2C19*2 genotype.

Ho S, Rawlins M, Ingram P, Boan P.

J Chemother. 2017 Oct;29(5):325-326. doi: 10.1080/1120009X.2017.1323395. Epub 2017 May 8. No abstract available.

PMID:
28482780
23.

Selective Photomechanical Detachment and Retrieval of Divided Sister Cells from Enclosed Microfluidics for Downstream Analyses.

Chen YC, Baac HW, Lee KT, Fouladdel S, Teichert K, Ok JG, Cheng YH, Ingram PN, Hart AJ, Azizi E, Guo LJ, Wicha MS, Yoon E.

ACS Nano. 2017 May 23;11(5):4660-4668. doi: 10.1021/acsnano.7b00413. Epub 2017 May 8.

PMID:
28480715
24.

A CONSORT analysis of randomised controlled trials for the treatment of invasive aspergillosis.

Jones BL, Richardson MD, Ingram PM, Agrawal SG.

Med Mycol. 2017 Aug 1;55(6):605-613. doi: 10.1093/mmy/myw133.

PMID:
27915306
25.

Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.

Marshalek JP, Sheeran PS, Ingram P, Dayton PA, Witte RS, Matsunaga TO.

J Control Release. 2016 Dec 10;243:69-77. doi: 10.1016/j.jconrel.2016.09.010. Epub 2016 Sep 26.

26.

EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells.

Bai S, Ingram P, Chen YC, Deng N, Pearson A, Niknafs YS, O'Hayer P, Wang Y, Zhang ZY, Boscolo E, Bischoff J, Yoon E, Buckanovich RJ.

Cancer Res. 2016 Nov 1;76(21):6396-6409. Erratum in: Cancer Res. 2017 Apr 15;77(8):2175.

27.
28.

Phylogenetic diversity, antimicrobial susceptibility and virulence characteristics of phylogroup F Escherichia coli in Australia.

Vangchhia B, Abraham S, Bell JM, Collignon P, Gibson JS, Ingram PR, Johnson JR, Kennedy K, Trott DJ, Turnidge JD, Gordon DM.

Microbiology. 2016 Nov;162(11):1904-1912. doi: 10.1099/mic.0.000367. Epub 2016 Sep 22.

PMID:
27666313
29.

Erratum to "The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing" [J. Microbiol. Methods 124 (2016) 10-12].

Goire N, Harnett GB, O'Reilly LC, Ingram PR, Leung MJ, Speers DJ, Healy PE, Inglis TJJ.

J Microbiol Methods. 2016 Sep;128:130. doi: 10.1016/j.mimet.2016.06.021. Epub 2016 Jul 6. No abstract available.

PMID:
27393044
30.

Single cell dual adherent-suspension co-culture micro-environment for studying tumor-stromal interactions with functionally selected cancer stem-like cells.

Chen YC, Zhang Z, Fouladdel S, Deol Y, Ingram PN, McDermott SP, Azizi E, Wicha MS, Yoon E.

Lab Chip. 2016 Aug 7;16(15):2935-45. doi: 10.1039/c6lc00062b. Epub 2016 Jul 6.

31.

Tigecycline use in the outpatient parenteral antibiotic therapy setting.

Ingram PR, Rawlins MD, Murray RJ, Roberts JA, Manning L.

Eur J Clin Microbiol Infect Dis. 2016 Oct;35(10):1673-7. doi: 10.1007/s10096-016-2709-6. Epub 2016 Jun 20.

PMID:
27325439
32.

High-Throughput Single-Cell Derived Sphere Formation for Cancer Stem-Like Cell Identification and Analysis.

Chen YC, Ingram PN, Fouladdel S, McDermott SP, Azizi E, Wicha MS, Yoon E.

Sci Rep. 2016 Jun 13;6:27301. doi: 10.1038/srep27301.

33.
34.

Endogenous pneumoconiosis: Analytical scanning electron microscopic analysis of a case.

Galeotti J, Sporn TA, Ingram P, Wahidi MM, Roggli VL.

Ultrastruct Pathol. 2016 May-Jun;40(3):159-62. doi: 10.3109/01913123.2016.1170084.

PMID:
27281119
35.

Self-stigma, personality traits, and willingness to seek treatment in a community sample.

Ingram PB, Lichtenberg JW, Clarke E.

Psychol Serv. 2016 Aug;13(3):300-307. doi: 10.1037/ser0000086. Epub 2016 Jun 2.

PMID:
27253319
36.

The detection of content-based invalid responding: a meta-analysis of the MMPI-2-Restructured Form's (MMPI-2-RF) over-reporting validity scales.

Ingram PB, Ternes MS.

Clin Neuropsychol. 2016 May;30(4):473-96. doi: 10.1080/13854046.2016.1187769. Epub 2016 May 23. Review.

PMID:
27214667
37.

The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing.

Goire N, Harnett GB, O'Reilly LC, Ingram PR, Leung MJ, Speers DJ, Healy PE, Inglis TJ.

J Microbiol Methods. 2016 May;124:10-2. doi: 10.1016/j.mimet.2016.03.001. Epub 2016 Mar 2. Erratum in: J Microbiol Methods. 2016 Sep;128:130.

PMID:
26945518
38.

Temporal flux in β-lactam resistance among Klebsiella pneumoniae in Western Australia.

Hall JM, Ingram PR, O'Reilly LC, Inglis TJJ.

J Med Microbiol. 2016 May;65(5):429-437. doi: 10.1099/jmm.0.000242. Epub 2016 Mar 4.

PMID:
26944048
39.

Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2.

Choi YJ, Ingram PN, Yang K, Coffman L, Iyengar M, Bai S, Thomas DG, Yoon E, Buckanovich RJ.

Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):E6882-8. doi: 10.1073/pnas.1507899112. Epub 2015 Nov 30.

40.

Genomic Characteristics of NDM-Producing Enterobacteriaceae Isolates in Australia and Their blaNDM Genetic Contexts.

Wailan AM, Paterson DL, Kennedy K, Ingram PR, Bursle E, Sidjabat HE.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):136-41. doi: 10.1128/AAC.01243-15. Print 2016 Jan.

41.
42.

Photo Quiz: A 66-Year-Old Man With Severe Sepsis.

Hart J, Kruger P, Ingram PR.

J Clin Microbiol. 2015 Oct;53(10):3109, 3389. doi: 10.1128/JCM.02824-13. No abstract available.

43.

High-Throughput Cancer Cell Sphere Formation for Characterizing the Efficacy of Photo Dynamic Therapy in 3D Cell Cultures.

Chen YC, Lou X, Zhang Z, Ingram P, Yoon E.

Sci Rep. 2015 Jul 8;5:12175. doi: 10.1038/srep12175.

44.

Single-cell Migration Chip for Chemotaxis-based Microfluidic Selection of Heterogeneous Cell Populations.

Chen YC, Allen SG, Ingram PN, Buckanovich R, Merajver SD, Yoon E.

Sci Rep. 2015 May 18;5:9980. doi: 10.1038/srep09980.

45.

A comparison of paediatric and adult infectious diseases consultations in Australia and New Zealand.

Blyth CC, Walls T, Cheng AC, Murray RJ, Fisher DA, Ingram PR, Davis JS; Australasian Society for Infectious Diseases Clinical Research Network; Australian New Zealand Paediatric Infectious Diseases Research Network.

Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1589-92. doi: 10.1007/s10096-015-2391-0. Epub 2015 Apr 29.

PMID:
25920492
46.

Pseudotumour formation in atheromatous coronary arteries.

Treacy AD, Norita K, Ingram PJ, Sheppard MN.

J Forensic Leg Med. 2015 May;32:73-6. doi: 10.1016/j.jflm.2015.02.004. Epub 2015 Mar 6.

PMID:
25882155
47.

Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.

Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers S, Sidjabat HE, Gunning E, De Almeida M, Styles K, Paterson DL; ASID CRN.

Int J Antimicrob Agents. 2015 Apr;45(4):351-8. doi: 10.1016/j.ijantimicag.2014.11.015. Epub 2015 Jan 13.

PMID:
25707371
48.

Appropriateness and determinants of antibiotic prescribing in an Australian emergency department.

O'Brien AP, Rawlins MD, Ingram PR.

Emerg Med Australas. 2015 Feb;27(1):83-4. doi: 10.1111/1742-6723.12346. Epub 2015 Jan 8. No abstract available.

PMID:
25627572
49.

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.

Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL.

Trials. 2015 Jan 27;16:24. doi: 10.1186/s13063-014-0541-9.

50.

Traceable clonal culture and chemodrug assay of heterogeneous prostate carcinoma PC3 cells in microfluidic single cell array chips.

Chung J, Ingram PN, Bersano-Begey T, Yoon E.

Biomicrofluidics. 2014 Nov 14;8(6):064103. doi: 10.1063/1.4900823. eCollection 2014 Nov.

Supplemental Content

Loading ...
Support Center